News Release

Major Patent For Pain Management Issued By USPTO

Date: Aug 08, 2002

TSX Venture Exchange Trading Symbol: WXI
http://www.wextech.ca
E-mail: wex@wextech.ca

International Wex Technologies Inc. (the "Company") is pleased to announce that the "United States Patent and Trademark Office" (USPTO) has officially issued to the Company a patent under the title of "Method of Analgesia".

This patent covers the use of TTX and other similar compounds for pain management. The invention relates to a method of producing analgesia in mammals, including human beings, experiencing pain by systemically administering an effective amount of a composition comprising essentially of a sodium channel blocking compound such as TTX. Palliative cancer pain, on which the Company is focusing during its ongoing clinical trials, is one of the major indications covered in the claims. In addition to the patent the Company owns for drug addiction treatment, this is another success in building up the Company's intellectual property assets. The Company currently has an additional nine patent applications pending and more to be filed with connection to its TTX platform technology.

In the area of neuro-bioscience, the Company is focusing on the fields of pain management, drug addiction treatment and anaesthesia. The Company is developing products that contain a sodium channel blocking compound and derivatives extracted from natural organic substance using its proprietary manufacturing technology.

For additional information on our products, view the Company website at http://www.wextech.ca or call Howard Milne, V.P. Corporate Communications, at 604-683-8880 or 1-800-722-7549.

Per: Donna Shum, Corporate Secretary

The Canadian Venture Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this News Release.